Baruch S Blumberg, MD, PhD: Publications

Baruch S Blumberg, MD, PhD

Publications 1990-1999

401.    Blumberg, B. S. Proc. International Conference on Prospects for Eradication of Hepatitis B Virus. Vaccine v8 Introduction pS5; Conclusion pS139, 1990.

402.    Blumberg, B. S., Millman, I., Venkateswaran, P. S. and Thyagarajan, S. P. Hepatitis B virus and primary hepatocellular carcinoma: Treatment of HBV carriers with Phyllanthus amarus. Vaccine v8 pS86-S92, 1990.

403.    Feitelson, M. A., Clayton, M. M. and Blumberg, B. S. X antigen/antibody markers in hepadnavirus infections. Presence and significance of hepadnavirus X gene product(s) in serum. Gastroenterology v98 p1071-1078, 1990.

404.    Blumberg, B. S. The importance of basic science for the AIDS epidemic, HIV and hepatitis B virus. Proc. Fourth International Conference organized by the Pontifical Council for Pastoral Assistance for Health Care Workers. Dolentium Hominum No. 13, year V, p40-43, 1990.

405.    Blattner, W. A., Saxinger, C., Riedel, D., Hull, B., Taylor, G., Cleghorn, F., Gallo, R., Blumberg, B. and Bartholomew, C. A study of HTLV-I and its associated risk factors in Trinidad and Tobago. JAIDS v3 p1102-1108, 1990.

406.    Blumberg, B. S., Millman, I., Venkateswaran, P. S. and Thyagarajan, S. P. Hepatitis B virus and hepatocellular carcinoma. Treatment of HBV carriers with Phyllanthus amarus.   ASEAN J. Clin. Sci. Monograph 11 p35-47, 1990.

407.    Unander, D. W., Venkateswaran, P. S., Millman, I., Bryan, H. H. and Blumberg, B. S. Phyllanthus species: Sources of new antiviral compounds. In Advances in New Crops. Janick, J. and Simon, J. E. (Eds.) Timber Press Inc., Portland, OR p518-521, 1990.

408.    Unander, D. W., Webster, G. L. and Blumberg, B. S. Records of usage or assays in Phyllanthus (Euphorbiaceae) I. Subgenera Isocladus, Kirganelia, Cicca and Emblica. J. Ethnopharmacol. v30 p233-264, 1990.

409.    Shrager, D. I., Blumberg, B. S., Blattner, W. A. and Kim, Norma N. Human T-cell leukemia virus type I and hepatitis B virus seropositivity in Philadelphia, 1969-1970. Hepatitis Scientific Memoranda No. 4 September 1990.

410.    Blumberg, B. S. Foreword. In Science Literacy, Policy, Evaluation, and other Essays. Garfield, E. ISI Press, Phila. PA pix-xi, 1990.

411.    Blumberg, B. S. Sex-related aspects of hepatitis B infection and its consequences. In Hepatitis B: A sexually transmitted disease in heterosexuals. Piot, P. and Andre, F. E. (Eds.) Elsevier Science Publishers B.V. (Biomedical Division) p3-7, 1990.

412.    Unander, D. W. and Blumberg, B. S. In vitro activity of Phyllanthus (Euphorbiaceae) species against the DNA polymerase of hepatitis viruses: Effects of growing environment and inter- and intra-specific differences. Economic Botany v45 p225-242, 1991.

413.    Stevens, R. G. and Blumberg, B. S. Serum albumin and mortality. (Letter to the Editor) Lancet v335, p351, 1990.

414.    Unander, D. W., Webster, G. L., and Blumberg, B. S. Uses and bioassays in Phyllanthus (Euphorbiaceae): a compilation. II. The subgenus Phyllanthus. J. Ethnopharmacol. v34 p97-133, 1991.

415.    Horiike, N., Blumberg, B. S., and Feitelson, M. A. Characteristics of hepatitis B X antigen, antibodies to X antigen, and antibodies to the viral polymerase during hepatitis B virus infection. J. Infect. Dis. v164 p1104-1112, 1991.

416.    Blumberg, B. S. Baruch S. Blumberg, Philadelphia. In Hans Popper: A Tribute. Berk, P. D., Schaffner, F., Schmid, R. (Eds.) Raven Press, New York, NY p19-21, 1992.

417.    Unander, D. W., Venkateswaran, P. S., Millman, I., and Blumberg, B. S. Inhibicion de la ADN polimerasa viral dependiente de virus hepatitis B por especies de Phyllanthus, effectos geneticos y ambientales sobre esta actividad. Brenesia v34 p27-40, 1991.

418.    Stevens, R. G. and Blumberg, B. S. Serum albumin and the risk of cancer. In  Macronutrients: Investigating Their Role in Cancer. Micozzi, M. S. and Moon, T. E. (Eds.) Marcell Dekker, Inc., New York, NY p283-292, 1992.

419.    Blumberg, B. S. Foreword In Iron Balance. Lauffler, R. B. St. Martin's Press, New York, NY pxiii-xviii, 1991.

420.    Lega, L., Vierucci, A., Blumberg, B. S., Saracco, G., Rizzetto, M., Zhu, M., and Feitelson, M. A. Hepatitis B x antigen and polymerase antibodies in the serum of hepatitis B carriers with or without delta virus infection. Effects of interferon treatment. J. Hepatol. v14 p286-293, 1992.

421.    Unander, D. W., Webster, G. L., and Blumberg, B. S. Usage and bioassays in Phyllanthus (Euphorbiaceae): a compilation III. The subgenera Eriococcus, Conami, Gomphidium, Botryanthus, Xylophylla and Phyllanthodendron, and a complete list of the species cited in the three-part series. J. Ethnopharmacol. v36 p103-112, 1992.

422.    Blumberg, B. S. Phyllanthus, compounds derived from it for the treatment of hepatitis B. In New Drugs From Natural Sources, Conference Documentation. London, U.K., organized by IBC Technical Services Ltd., 13-14 June 1991.  

423.    Blumberg, B. S. Ethics and cancer therapy. Biomed. & Pharmacother. v47 p393-395, 1993.

424.    Stevens, R. G., Graubard, B. I., Micozzi, M. S., Nerushi, K. and Blumberg, B. S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer v56 p364-369, 1994.

425.    Block, T. M., Lu, X., Platt, F. M., Foster, G. R., Gerlich, W. H., Blumberg, B. S., and Dwek, R. A. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc. Natl. Acad. Sci., USA v91 p2235-2239, 1994.  

426.    Feitelson, M., Lega, L., Guo, J., Resti, M., Rossi, M.E., Azzari, C., Blumberg, B. S., and Vierucci, A. Pathogenesis of posttransfusion viral hepatitis in children with B-thalassemia. Hepatology v19 p558-568, 1994.

427.    Dube, D. K., Dube, S., Erensoy, S., Jones, B., Bryz-Gornia, V., Spicer, T., Love, J., Saksena, N., Lechat, M. F., Shrager, D. I., Dosik, H., Glaser, J., Levis, W., Blatter, W., Montagna, R., Blumberg, B. S., and Poiesz, B. J. Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire. Virology v202 p379-389, 1994.  

428.    Blumberg, B. S. The hepatitis B virus: Discovery and application. Oxford Innovation News v13 p2-5, 1994.

429.    Blumberg, B. S. The hepatitis viruses: Accomplishments and problems. In Viral Hepatitis and Liver Disease. The 1993 International Symposium on Viral Hepatitis and Liver Disease, May 10-14, 1993, Tokyo, Japan. Nishioka, K., Suzuki, H., Mishiro, S., and Oda, T. (Eds.) Springer-Verlag Tokyo, p7-9, 1994.

430.    Blumberg, B. S. Scientific process and the hepatitis B virus. Creativity Research J. v7 p315-325, 1994. 

431.    Blumberg, B. S. The importance of basic research. The Financial Times, London, January 23, 1995.

432.    Feitelson, M. A., Duan, L. X., Guo, J., Horiike, N., McIntyre, G., Blumberg, B. S., Thomas, H. C., and Carman, W. Precore and X region mutants in hepatitis B virus infections among renal dialysis patients. J. Viral Hepatitis v2 p19-31, 1995.

433.    Blumberg, B. S. Venture capital and the development of new scientific ideas. Science & Public Affairs p14-16 (winter) 1994.

434.    Unander, D. W., Webster, G. L., and Blumberg, B. S. Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. J. Ethnopharmacology v45 p1-18, 1995.

435.    McLean, A. and Blumberg, B. S. Modelling the impact of mass vaccination against hepatitis B. I. Model formulation and parameter estimation. Proc. R. Soc. London B v256 p7-15, 1994.

436.    Dube, D. K., Dube, S., Sherman, M. P., Love, J., Saksena, N. K., Harrington, W. J. Jr., Ferrer, J. F., Papsidero, L., Dyster, L., Yanagihara, R., Williams, A. E., Glaser, J. B., Herve, V. M. A., Barre-Sinoussi, F., Blumberg, B. S. and Poiesz, B. J. Estimation of genetic heterogeneity in primate T-cell lymphoma/leukemia viruses by PCR. In Methods in Neurosciences, G. Sarkar, (Ed.), Academic Press Inc., v26 p358-380, 1995.

437.    Blumberg, B. S. Complex interactions of hepatitis B virus with its host and environment. J. Royal College Physicians London v29 p31-40, 1995.  

438.    Blumberg, B. S. Hepatitis B virus and vaccine In Immunology: The Making of Modern Science, R. B. Gallagher, J. Gilder, G. J. V. Nossal, and G. Salvatore, (Eds.), p223-229, Academic Press, 1995.

439.    Blumberg, B. S. Personal Viewpoint: Complexity and the hepatitis viruses. Gut v35 p1770-1771, 1994.

440.    Payne, R. J. H., Nowak, M. A., and Blumberg, B. S. Analysis of a cellular model to account for the natural history of infection by the hepatitis B virus and its role in the development of primary hepatocellular carcinoma. J. Theor. Biol. v159 p215-240, 1992.

441.    Feitelson, M. A., Duan, L.-X., Guo, J., Sun, B., Woo, J., Steensma, K., Horiike, N., and Blumberg, B. S. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J. Infect. Dis. v172 p713-722, 1995.

442.    Blumberg, B. S. The Hepatitis B Story: Dr. Baruch Blumberg discusses the discovery which earned a Nobel Prize. The Newsletter of the Hepatitis B Foundation v3 p2, 1995.

443.    Blumberg, B. S. Foreword In Frontiers of Complexity: The Search for Order in a Chaotic World. Coveney, P. and Highfield, R. Ballantine Books, a division of Random House, Inc., New York, NY, pxi-xiv, 1995.

444.    Blumberg, B. S. New Knowledge for Health In 2020 Vision Health in the 21st Century. Institute of Medicine 25th Anniversary Symposium 1995; p81-88, National Academy Press, 1996.

445.    Chen, D-S., Hsu, H-M., Bennett, C. L., Pajeau, T. S., Blumberg, B., Chang, P-Y., Nishioka, K. ,Huang, A., and Sung, J-L. A program for eradication of hepatitis B from Taiwan by a 10 year, four-dose vaccination program. Cancer Causes and Control v7 p305-311, 1996.

446.    Payne, R. J. H., Nowak, M., and Blumberg, B. S. The dynamics of hepatitis B virus. Proc. Natl. Acad. Sci. USA v92 p6542-6546, 1996.

447.   Blumberg, B. S. Reflections on a two-wheel way of life. London Telegraph, Saturday, 8 October 1994.  

448.    Blumberg, B. S. Medical Research for the Next Millennium. In The Cambridge Review, N. Spivey (ed), Cambridge University Press, v117 p3-8 1996.

449.    Blumberg, B. S. Interaction of Species. In The Web of Life, G. Padmanaban, M. Biswas, M. S. Shaila, and S. Vishveshwara (eds), Harwood Academic Publishers, The Netherlands, p1-8, 1997.

450.    Blumberg, B. S. Complexity and the hepatitis B virus. Antiviral Therapy v1 p21-24, 1996.

451.    Mehta, A., Lu, X., Block, T. M., Blumberg, B. S., and Dwek, R. A. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proc. Natl. Acad. Sci. USA v94 p1822-1827, 1997.

452.    Lu, X., Mehta, A., Dadmarz, M., Dwek, R., Blumberg, B. S., and Block, T. M. Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited. Proc. Natl. Acad. Sci. USA v94 p2380-2385, 1997.

453.    Blumberg, B. S. The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma. Res. Virol. v148 p91-94, 1997.

454.    Blumberg, B. S. Hepatitis B virus, the vaccine and the control of primary cancer of the liver. Proc. Natl. Acad. Sci. USA v94, 7121-7125, 1997.

455.    Blumberg, B. S. The Jayne Lecture: Reflections on the future of medical science. Proceedings of the American Philosophical Society v141 p125-140, 1997.

456.    Blumberg, B. S. Alexander George (Sandy) Ogston, MA, DPhil, DSc, FRS, 1911-96. In Trinity College Oxford Report 1996. Abbey Press, Abingdon, Oxon OX14 3JW, p17-21, 1996.

457.    Lechat, M. F., Shrager, D. I., Declercq, E., Bertrand, F., Blattner, W. A., and Blumberg, B. S. Decreased survival of HTLV-1 carriers in leprosy patients from the Democratic Republic of the Congo: A historical prospective study. J. Acquired Immune Deficiency Syndromes and Human Retrovirology v15 p387-390, 1997. PDF version

458.    Block, Timothy M., Lu, Xyanyong, Mehta, Anand S., Blumberg, Baruch S., Tennant, Bud, Ebling, Mathew, Korba, Brent, Lansky, David M., Jacob, Gary S., and Dwek, Raymond A. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking. Nature Medicine v4 p610-614, 1998.

459.    Blumberg, Baruch S. Factors influencing the course of hepatitis B virus infection. In Therapies for Viral Hepatitis, R.F. Schinazi, J-P. Sommadossi, H.C. Thomas, (eds). International Medical Press Ltd., London WC1V 6QA UK, p431-434, 1998.

460.  Blumberg, Baruch S. A case history of plant-derived drug research: Phyllanthus and hepatitis B virus. In Medicinal Plants: Their Role in Health and Biodiversity, Timothy R. Tomlinson and Olayiwola Akerele, (eds). University of Pennsylvania Press, Philadelphia, Pennsylvania 19104-4011, p3-10, 1998.

461.  Zitzmann, N., Mehta, A.S., Carrouée, S., Butters, T.D., Platt, F.M., McCauley, J., Blumberg, B.S., Dwek, R.A., and Block, T.M. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents. Proc. Natl. Acad. Sci. USA v96 11878-11882, 1999.